1. Home
  2. ACTU vs DLNG Comparison

ACTU vs DLNG Comparison

Compare ACTU & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • DLNG
  • Stock Information
  • Founded
  • ACTU 2015
  • DLNG 2013
  • Country
  • ACTU United States
  • DLNG Greece
  • Employees
  • ACTU N/A
  • DLNG N/A
  • Industry
  • ACTU
  • DLNG Marine Transportation
  • Sector
  • ACTU
  • DLNG Consumer Discretionary
  • Exchange
  • ACTU NYSE
  • DLNG Nasdaq
  • Market Cap
  • ACTU 154.3M
  • DLNG 143.7M
  • IPO Year
  • ACTU 2024
  • DLNG 2013
  • Fundamental
  • Price
  • ACTU $6.96
  • DLNG $3.78
  • Analyst Decision
  • ACTU Strong Buy
  • DLNG
  • Analyst Count
  • ACTU 1
  • DLNG 0
  • Target Price
  • ACTU $20.00
  • DLNG N/A
  • AVG Volume (30 Days)
  • ACTU 36.4K
  • DLNG 43.3K
  • Earning Date
  • ACTU 05-21-2025
  • DLNG 03-06-2025
  • Dividend Yield
  • ACTU N/A
  • DLNG 2.57%
  • EPS Growth
  • ACTU N/A
  • DLNG 112.55
  • EPS
  • ACTU N/A
  • DLNG 1.40
  • Revenue
  • ACTU N/A
  • DLNG $156,403,000.00
  • Revenue This Year
  • ACTU N/A
  • DLNG N/A
  • Revenue Next Year
  • ACTU N/A
  • DLNG $0.37
  • P/E Ratio
  • ACTU N/A
  • DLNG $2.74
  • Revenue Growth
  • ACTU N/A
  • DLNG N/A
  • 52 Week Low
  • ACTU $5.51
  • DLNG $2.81
  • 52 Week High
  • ACTU $11.73
  • DLNG $5.65
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • DLNG 37.35
  • Support Level
  • ACTU N/A
  • DLNG $3.88
  • Resistance Level
  • ACTU N/A
  • DLNG $3.99
  • Average True Range (ATR)
  • ACTU 0.00
  • DLNG 0.12
  • MACD
  • ACTU 0.00
  • DLNG 0.02
  • Stochastic Oscillator
  • ACTU 0.00
  • DLNG 12.94

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About DLNG Dynagas LNG Partners LP Common Units

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.

Share on Social Networks: